Your browser doesn't support javascript.
loading
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma.
Nieuwenhuis, Esther A; van Munster, Sanne N; Meijer, Sybren L; Brosens, Lodewijk A A; Jansen, Marnix; Weusten, Bas L A M; Alvarez Herrero, Lorenza; Alkhalaf, Alaa; Schenk, Ed; Schoon, Erik J; Curvers, Wouter L; Koch, Arjun D; van de Ven, Steffi E M; Verheij, Eva P D; Nagengast, Wouter B; Westerhof, Jessie; Houben, Martin H M G; Tang, Thjon; Bergman, Jacques J G H M; Pouw, Roos E.
Afiliación
  • Nieuwenhuis EA; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands.
  • van Munster SN; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands.
  • Meijer SL; Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.
  • Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Jansen M; Department of Pathology, UCL Cancer Institute and University College London Hospital, NHS Trust, London, UK.
  • Weusten BLAM; Department of Gastroenterology and Hepatology University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Alvarez Herrero L; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Alkhalaf A; Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands.
  • Schenk E; Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands.
  • Schoon EJ; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands; Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.
  • Curvers WL; Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.
  • Koch AD; Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • van de Ven SEM; Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Verheij EPD; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands.
  • Nagengast WB; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen University, Groningen, the Netherlands, (12)Department of Gastroenterology and Hepatology, Haga Teaching Hospital, Den Haag, the Netherlands.
  • Westerhof J; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen University, Groningen, the Netherlands, (12)Department of Gastroenterology and Hepatology, Haga Teaching Hospital, Den Haag, the Netherlands.
  • Houben MHMG; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen University, Groningen, the Netherlands, (12)Department of Gastroenterology and Hepatology, Haga Teaching Hospital, Den Haag, the Netherlands.
  • Tang T; Department of Gastroenterology and Hepatology, Ijsselland Hospital, Capelle aan den Ijssel, the Netherlands.
  • Bergman JJGHM; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands.
  • Pouw RE; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands.
Gastrointest Endosc ; 96(2): 237-247.e3, 2022 08.
Article en En | MEDLINE | ID: mdl-35288149
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Gastrointest Endosc Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Gastrointest Endosc Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos